Nalaganje...
Continuation treatment of major depressive disorder: is there a case for duloxetine?
Duloxetine is a serotonin–noradrenaline reuptake inhibitor with established efficacy for the short-term treatment of major depressive disorder. Efficacy in continuation treatment (greater than six months of continuous treatment) has been established from both open and placebo-controlled relapse prev...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2846146/ https://ncbi.nlm.nih.gov/pubmed/20368904 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|